Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

Marieke G. G. Sturkenboom; Onno W. Akkerman; Mathieu S. Bolhuis; Wiel C. M. de Lange; Tjip S. van der Werf; Jan-Willem C. Alffenaar

doi:10.1128/AAC.05173-14

Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

^*Corresponding author for this work

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

8 Citations (Scopus)

369 Downloads (Pure)

Original language	English
Pages (from-to)	2474-2474
Number of pages	1
Journal	Antimicrobial Agents and Chemotherapy
Volume	59
Issue number	4
DOIs	https://doi.org/10.1128/AAC.05173-14
Publication status	Published - Apr-2015

Keywords

1ST-LINE ANTITUBERCULOSIS DRUGS
H PLASMA-CONCENTRATIONS
CLINICAL-SIGNIFICANCE
RESISTANCE

Access to Document

10.1128/AAC.05173-14

Antimicrob._Agents_Chemother._2015_Sturkenboom_2474Final publisher's version, 109 KB

Handle.net

Persistent link

Cite this

@article{afbcf25d521743298f1285ba962e7326,

title = "Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future",

keywords = "1ST-LINE ANTITUBERCULOSIS DRUGS, H PLASMA-CONCENTRATIONS, CLINICAL-SIGNIFICANCE, RESISTANCE",

author = "Sturkenboom, \{Marieke G. G.\} and Akkerman, \{Onno W.\} and Bolhuis, \{Mathieu S.\} and \{de Lange\}, \{Wiel C. M.\} and \{van der Werf\}, \{Tjip S.\} and Alffenaar, \{Jan-Willem C.\}",

year = "2015",

month = apr,

doi = "10.1128/AAC.05173-14",

language = "English",

volume = "59",

pages = "2474--2474",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "1098-6596",

publisher = "AMER SOC MICROBIOLOGY",

number = "4",

}

Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future. / Sturkenboom, Marieke G. G.; Akkerman, Onno W.; Bolhuis, Mathieu S. et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 59, No. 4, 04.2015, p. 2474-2474.

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

TY - JOUR

T1 - Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future

AU - Sturkenboom, Marieke G. G.

AU - Akkerman, Onno W.

AU - Bolhuis, Mathieu S.

AU - de Lange, Wiel C. M.

AU - van der Werf, Tjip S.

AU - Alffenaar, Jan-Willem C.

PY - 2015/4

Y1 - 2015/4

KW - 1ST-LINE ANTITUBERCULOSIS DRUGS

KW - H PLASMA-CONCENTRATIONS

KW - CLINICAL-SIGNIFICANCE

KW - RESISTANCE

U2 - 10.1128/AAC.05173-14

DO - 10.1128/AAC.05173-14

M3 - Letter (Research letter)

C2 - 25762792

SN - 1098-6596

VL - 59

SP - 2474

EP - 2474

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 4

ER -